← FDA Drug Approvals (Drugs@FDA)

PALBOCICLIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2026-02-25

Drug application

FDA Application #

ANDA212980

Application type

Abbreviated New Drug Application (Generic)

Brand name

PALBOCICLIB

Generic name

Palbociclib

Active ingredients

PALBOCICLIB

Dosage form

CAPSULE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2026-02-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown